NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Wockhardt Limited (NSE: WOCKPHARMA)

 
WOCKPHARMA Technical Analysis
5
As on 26th Apr 2024 WOCKPHARMA SHARE Price closed @ 573.75 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1015.24 & Strong Sell for SHORT-TERM with Stoploss of 1045.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

WOCKPHARMASHARE Price

Open 576.00 Change Price %
High 595.00 1 Day 3.10 0.54
Low 565.00 1 Week -9.10 -1.56
Close 573.75 1 Month 42.45 7.99
Volume 440684 1 Year -1370.75 -70.49
52 Week High 1944.50 | 52 Week Low 322.45
 
NSE INDIA Most Active Stocks
IDEA 14.00 0.72%
YESBANK 26.15 0.77%
IRFC 158.05 5.19%
GMRINFRA 90.75 6.58%
HUDCO 228.10 12.34%
MAHABANK 67.65 3.68%
SAIL 168.55 2.18%
NHPC 92.55 1.65%
TATASTEEL 165.80 -1.13%
IDFCFIRSTB 84.80 1.68%
 
NSE INDIA Top Gainers Stocks
ROSSELLIND 468.35 20.00%
MGEL 23.25 19.85%
KIRLOSIND 5232.65 12.84%
HUDCO 228.10 12.34%
DPABHUSHAN 1133.45 10.42%
KECL 130.60 10.30%
EXCEL 0.55 10.00%
ACL 98.15 9.79%
ACL 98.15 9.79%
ACL 98.15 9.79%
 
NSE INDIA Top Losers Stocks
LTTS 4778.10 -7.81%
BAJFINANCE 6731.20 -7.73%
DBSTOCKBRO 50.90 -5.91%
COMPUSOFT 33.95 -5.56%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
KSB 4674.75 -5.21%
 
 
WOCKPHARMA
Daily Charts
WOCKPHARMA
Intraday Charts
Whats New @
Bazaartrend
WOCKPHARMA
Free Analysis
 
WOCKPHARMA Important Levels Intraday
RESISTANCE631.56
RESISTANCE613.02
RESISTANCE601.56
RESISTANCE590.10
SUPPORT557.40
SUPPORT545.94
SUPPORT534.48
SUPPORT515.94
 
WOCKPHARMA Target April 2024
4th UP Target2724.94
3rd UP Target2474.65
2nd UP Target2319.94
1st UP Target2165.23
1st DOWN Target1723.78
2nd DOWN Target1569.07
3rd DOWN Target1414.36
4th DOWN Target1164.07
 
WOCKPHARMA Weekly Target
4th UP Target708.11
3rd UP Target667.94
2nd UP Target643.11
1st UP Target618.28
1st DOWN Target547.43
2nd DOWN Target522.60
3rd DOWN Target497.77
4th DOWN Target457.60
 
WOCKPHARMA Target2024
4th UP Target2724.94
3rd UP Target2474.65
2nd UP Target2319.94
1st UP Target2165.23
1st DOWN Target1723.78
2nd DOWN Target1569.07
3rd DOWN Target1414.36
4th DOWN Target1164.07
 
 
WOCKPHARMA Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is 33.92 Sideways
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 267.63
10 Day Avg Volume Traded -12.49 % Less then 10 Day Average Volume
 
WOCKPHARMA Other Details
Segment EQ
Market Capital 47977787392.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
WOCKPHARMA Address
WOCKPHARMA
 
WOCKPHARMA Latest News
 
Your Comments and Response on Wockhardt Limited
 
WOCKPHARMA Business Profile
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, Europe, and internationally. The company offers generic products comprising injectables, such as cephalosporins and non-cephalosporins; molecules; and value-added generics. Its biopharmaceutical products include Glaritus, an insulin analog; Wosulin, an r-DNA insulin; Wepox, a recombinant erythropoietin that is used in the treatment of anemia caused by cancer and chronic renal failure; and Biovac-B, a hepatitis B vaccine. The company also provides contract manufacturing services for sterile injectables, lyophilisation, and other dosage forms; and research services. It develops various molecules primarily in the area of infectious disease, such as WCK 5222, WCK 4282, WCK 4873, WCK 771 and WCK 2349, and WCK 6777 molecules. The company was incorporated in 1999 and is headquartered in Mumbai, India. Wockhardt Limited is a subsidiary of Themisto Trustee Company Private Limited. Address: Wockhardt Towers, Mumbai, India, 400051
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service